quinazolines has been researched along with Anterior Horn Cell Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ClĂ©ment-DuchĂȘne, C; Lamaze, R; Martinez, L | 1 |
Liu, R; Liu, XP; Trieu, VN; Uckun, FM | 1 |
2 other study(ies) available for quinazolines and Anterior Horn Cell Disease
Article | Year |
---|---|
[Primary lateral sclerosis and lung adenocarcinoma].
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Causality; Diagnosis, Differential; Dysarthria; Electromyography; Fatal Outcome; Female; Gefitinib; Glutamates; Guanine; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Motor Neuron Disease; Motor Neurons; Multimodal Imaging; Paraneoplastic Syndromes, Nervous System; Pemetrexed; Pleural Effusion, Malignant; Positron-Emission Tomography; Quadriplegia; Quinazolines; Tomography, X-Ray Computed | 2013 |
A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Animals; Antioxidants; Disease Models, Animal; Enzyme Inhibitors; Genetic Variation; Genistein; Heterozygote; Humans; Janus Kinase 3; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Motor Neuron Disease; Neuroprotective Agents; Paralysis; Protein-Tyrosine Kinases; Quinazolines; Superoxide Dismutase | 2000 |